Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07226804
Status
Recruiting
Apply to this trial

Conditions

  • Pulsed Field Ablation
  • Thyroid Nodules

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Questionnaire — OTHER
    patient-reported outcomes questionnaire

Study Details

To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.

Key Dates

Start date
Nov 14, 2025
Status verified
May 2026
Primary completion
Aug 31, 2028
Completion
Aug 31, 2030

Study Design

Enrollment
30 participants (estimated)

Primary Outcome Measure

Quality-of-life Questionnaire [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Victoria E Banuchi, MD
[email protected]
346-217-8668
Victoria E Banuchi, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies